10 - Vascular / 10.01 - Vascular Stents / 10.01.03 - Bioresorbable Drug Eluting Stent

10.01.03.01 - Everolimus Eluting BTK Resorbable Scaffold System

1 devices · 1 sponsors

March 2027 window closes in 92 days

Median benefit

$2477.00

Range

$2477–2477

Comparator candidates

Code	Device · sponsor	Benefit	Tier 1 comparator?
SJ498	Esprit BTK Everolimus Eluting Resorbable Scaffold System ABBOTT MEDICAL AUSTRALIA PTY LTD.	$2477.00	eligible

1 device(s).

Tier pre-screener

Indicative only — pathway choice is the sponsor's responsibility.

TGA class of your device Well-established technology? Listing in this existing grouping? Interchangeable with a comparator here?

4-year benefit estimate

For the HPP utilisation section — arithmetic on your inputs.

Benefit $ Units/yr (low) Units/yr (high)

Year	Low	High
4-year total

Data: current Prescribed List · Calculations are based on published government data and figures you enter — a lookup and arithmetic tool, not regulatory or billing advice · Not an official government service.